Medicare Enrolled
Dr. Marianna Golden, M.D.
Neurology · West Nyack, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Golden from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Golden?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Golden
Dr. Marianna Golden is a neurology specialist in West Nyack, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Golden performed 1,180 Medicare services across 1,012 unique beneficiaries.
Between the years covered by Open Payments, Dr. Golden received a total of $15,767 from 77 pharmaceutical and/or device companies across 874 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Golden is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 26% volume in NY
$15,767 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,180
Medicare services
Top 26% in NY for neurology
1,012
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~62 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
386 | $109 | $537 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
139 | $147 | $764 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
100 | $37 | $242 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
100 | $100 | $648 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
95 | $124 | $405 |
| Use of electrodes during balance testing Application of electrodes to monitor physiological responses during a balance assessment. |
94 | $10 | $114 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
75 | $79 | $409 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
65 | $163 | $766 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
51 | $72 | $267 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
43 | $4 | $64 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $157 | $748 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,767
Total received (2018-2024)
Avg $2,252/year across 7 years
Top 20% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
874
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,592 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$175 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,522
2023
$2,495
2022
$2,581
2021
$2,109
2020
$1,801
2019
$1,932
2018
$2,327
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$927
UCB, Inc.
$301
Sumitomo Pharma America, Inc.
$166
Lilly USA, LLC
$152
SK Life Science, Inc.
$134
Aucta Pharmaceuticals, Inc.
$124
Grifols USA, LLC
$112
Lundbeck LLC
$100
Kyowa Kirin, Inc.
$79
Amneal Pharmaceuticals LLC
$73
PFIZER INC.
$60
TG Therapeutics, Inc.
$47
Eisai Inc.
$44
Novartis Pharmaceuticals Corporation
$42
Takeda Pharmaceuticals U.S.A., Inc.
$27
Genentech USA, Inc.
$26
Otsuka America Pharmaceutical, Inc.
$25
CATALYST PHARMACEUTICALS, INC.
$23
SCILEX PHARMACEUTICALS INC.
$21
ARGENX US, INC.
$20
Medtronic, Inc.
$17
Top 3 companies account for 55.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,461
Lilly USA, LLC
$883
Allergan, Inc.
$705
UCB, Inc.
$700
Novartis Pharmaceuticals Corporation
$628
Kyowa Kirin, Inc.
$611
Amgen Inc.
$594
EMD Serono, Inc.
$494
SK Life Science, Inc.
$492
GENZYME CORPORATION
$470
Adamas Pharmaceuticals, Inc.
$429
Lundbeck LLC
$397
PFIZER INC.
$371
Allergan Inc.
$358
Sumitomo Pharma America, Inc.
$330
ACADIA Pharmaceuticals Inc
$318
Grifols USA, LLC
$292
Celgene Corporation
$291
Sunovion Pharmaceuticals Inc.
$287
Amneal Pharmaceuticals LLC
$243
Biogen, Inc.
$231
Genentech USA, Inc.
$215
Alexion Pharmaceuticals, Inc.
$212
Biohaven Pharmaceuticals, Inc.
$211
Eisai Inc.
$203
Mallinckrodt LLC
$194
EISAI INC.
$193
Assertio Therapeutics, Inc.
$180
Upsher-Smith Laboratories LLC
$159
Currax Pharmaceuticals LLC
$134
Abbott Laboratories
$129
Aucta Pharmaceuticals, Inc.
$124
Supernus Pharmaceuticals, Inc.
$118
Avanir Pharmaceuticals, Inc.
$104
Mallinckrodt Enterprises LLC
$95
Biohaven Pharmaceutical Holding Company Ltd.
$94
CSL Behring
$91
Vertical Pharmaceuticals, LLC
$91
Acorda Therapeutics, Inc
$85
AbbVie Inc.
$83
Welch Allyn
$79
MITSUBISHI TANABE PHARMA AMERICA, INC.
$78
Janssen Pharmaceuticals, Inc
$78
UPSHER-SMITH LABORATORIES LLC
$75
Neurocrine Biosciences, Inc.
$73
Teva Pharmaceuticals USA, Inc.
$69
Mallinckrodt Hospital Products Inc.
$66
Promius Pharma LLC
$63
Medtronic USA, Inc.
$62
Boston Scientific Corporation
$55
Otsuka America Pharmaceutical, Inc.
$53
Almatica Pharma LLC
$53
IMPEL PHARMACEUTICALS INC.
$48
TG Therapeutics, Inc.
$47
ASSERTIO THERAPEUTICS, Inc.
$47
Alnylam Pharmaceuticals Inc.
$42
Merz North America, Inc.
$41
Medtronic, Inc.
$38
ARGENX US, INC.
$38
Exeltis, USA Inc.
$31
ARBOR PHARMACEUTICALS, INC.
$31
Corium, LLC
$27
Takeda Pharmaceuticals U.S.A., Inc.
$27
Catalyst Pharmaceuticals, Inc.
$25
Impax Laboratories, Inc.
$24
CATALYST PHARMACEUTICALS, INC.
$23
SCILEX PHARMACEUTICALS INC.
$21
AbbVie, Inc.
$17
Xeris Pharmaceuticals, Inc.
$17
AstraZeneca Pharmaceuticals LP
$17
Aprecia Pharmaceuticals, LLC
$16
Bausch Health US, LLC
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
Arbor Pharmaceuticals, Inc.
$14
Avion Pharmaceuticals
$14
Egalet US Inc
$13
Validus Pharmaceuticals LLC
$12
Top 3 companies account for 25.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Andexxa · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CAMBIA · COMIRNATY · CONTRAVE · CREXONT · Cambia · Duopa · EMGALITY · Equetro · FABRAZYME · FIRDAPSE · FYCOMPA · FreeStyle Libre · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - Pain Management · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · Motpoly XR · NAMZARIC · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ocrevus · PAXLOVID · PERCEPT PC BRAINSENSE · PURIFIED CORTROPHIN GEL · Percept · Privigen · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · REYVOW · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · Spritam · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VUMERITY · VYEPTI · VYVGART · Vimpat · XCOPRI · XEOMIN · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
840
Per 100K population
247.8
County median income
$110,631
Nearest hospital
NYACK HOSPITAL
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Golden is a clinical cardiology specialist, with above-average Medicare volume (top 26% in NY), with low-engagement industry engagement in the top 20% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Golden experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Golden performed 386 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Golden receive payments from pharmaceutical companies?
Yes. Dr. Golden received a total of $15,767 from 77 companies across 874 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Golden's costs compare to other neurologists in West Nyack?
Dr. Golden's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Golden) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in West Nyack
Browse neurologists in West Nyack ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology